We are live on ! Find out more
LP

Longaeva Partners Portfolio holdings

AUM $4.58B
1-Year Est. Return 43.91%
This Fund
S&P 500
This Quarter Est. Return
+20.82%
1 Year Est. Return
+43.91%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.58B
AUM Growth
+$1.88B
Cap. Flow
+$1.03B
Cap. Flow %
22.6%
Top 10 Hldgs %
29.9%
Holding
435
New
231
Increased
47
Reduced
58
Closed
96

Top Buys

Rank Stock Value
1
SPCX
SpaceX
SPCX
+$101M
2
JPM icon
JPMorgan Chase
JPM
+$79.2M
3
MCO icon
Moody's
MCO
+$58.8M
4
FITB
Fifth Third Bancorp
FITB
+$58.5M
5
LPLA icon
LPL Financial
LPLA
+$56M

Sector Composition

Rank Sector Weight
1 Miscellaneous 24.82%
2 Financials 20.39%
3 Healthcare 17.29%
4 Industrials 14.57%
5 Technology 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PM icon
201
Philip Morris
PM
$289B
$3.83M 0.08%
+21,153
New +$3.67M
MANH icon
202
Manhattan Associates
MANH
$12B
$3.78M 0.08%
+27,176
New +$3.74M
POOL icon
203
Pool Corp
POOL
$6.47B
$3.76M 0.08%
+17,481
New +$3.49M
GM icon
204
General Motors
GM
$73.5B
$3.75M 0.08%
+48,683
New +$3.82M
UCTT
205
Ultra Clean Holdings
UCTT
$3.4B
$3.75M 0.08%
26,305
-18,699
-42% -$1.65M
COMP icon
206
Compass
COMP
$8.2B
$3.7M 0.08%
+300,000
New +$2.5M
CVS icon
207
CVS Health
CVS
$122B
$3.7M 0.08%
+35,732
New +$3.19M
EXLS icon
208
EXL Service
EXLS
$5.3B
$3.68M 0.08%
+142,246
New +$4.19M
BX icon
209
Blackstone
BX
$96.9B
$3.65M 0.08%
+31,032
New +$3.73M
MAR icon
210
Marriott International
MAR
$86.4B
$3.61M 0.08%
9,748
-12,352
-56% -$4.56M
PACB icon
211
Pacific Biosciences
PACB
$401M
$3.56M 0.08%
+2,118,231
New +$3.08M
AIT icon
212
Applied Industrial Technologies
AIT
$11.9B
$3.55M 0.08%
+10,508
New +$3.22M
AVGO icon
213
Broadcom
AVGO
$1.73T
$3.5M 0.08%
+9,270
New +$3.72M
P
214
Everpure Inc
P
$32.3B
$3.47M 0.08%
+44,087
New +$3.23M
DK icon
215
Delek US
DK
$4.61B
$3.4M 0.07%
+66,914
New +$2.97M
FSS icon
216
Federal Signal
FSS
$7.17B
$3.38M 0.07%
+26,325
New +$3.02M
RGEN icon
217
Repligen
RGEN
$9.31B
$3.36M 0.07%
+24,616
New +$3.02M
MTZ icon
218
MasTec
MTZ
$19.3B
$3.32M 0.07%
7,968
-5,046
-39% -$1.93M
VVV icon
219
Valvoline
VVV
$3.87B
$3.27M 0.07%
+82,777
New +$2.88M
LNTH icon
220
Lantheus
LNTH
$6.58B
$3.22M 0.07%
29,051
-354,894
-92% -$33.1M
EXPO icon
221
Exponent
EXPO
$3.21B
$3.19M 0.07%
+54,254
New +$3.33M
MLTX icon
222
MoonLake Immunotherapeutics
MLTX
$1.17B
$3.15M 0.07%
161,557
-248,443
-61% -$4.5M
EQT icon
223
EQT Corp
EQT
$34.2B
$3.09M 0.07%
+58,113
New +$3.26M
KO icon
224
Coca-Cola
KO
$377B
$3.02M 0.07%
+37,215
New +$2.94M
ACAD icon
225
Acadia Pharmaceuticals
ACAD
$4.77B
$2.97M 0.06%
+117,318
New +$2.58M

Similar funds

Longaeva Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Longaeva Partners held 435 positions worth $4.58B, up 69% from $2.7B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Longaeva Partners deployed $1.03B of net new capital in Q2 2026, opening 231 new positions and adding to 47 existing holdings. Its largest new stake was SpaceX: 596,829 shares worth $102M.

By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was ACM Research, an estimated $48.8M trimmed.

  • Longaeva Partners's largest Q2 2026 buy was SpaceX: 596,829 shares worth $102M.
  • Longaeva Partners added most to Mettler-Toledo International in Q2 2026, an estimated $39.4M increase.
  • Longaeva Partners's biggest Q2 2026 reduction was ACM Research, cutting an estimated $48.8M.
  • Longaeva Partners fully exited PNC Financial Services in Q2 2026, selling an estimated $68M.
  • Longaeva Partners's ten largest holdings make up 30% of its $4.58B portfolio in Q2 2026.
  • Longaeva Partners opened 231 new positions and closed 96 in Q2 2026.
  • Longaeva Partners's portfolio value rose 69% quarter-over-quarter to $4.58B.

Based on Longaeva Partners's 13F filing for Q2 2026, filed 14 Aug 2026.